Authors:
HJORTH M
HOMBERG E
RODJER S
TURESSON I
WESTIN J
WISLOFF F
Citation: M. Hjorth et al., SURVIVAL IN CONVENTIONALLY TREATED YOUNGER (LESS-THAN-60 YEARS) MULTIPLE-MYELOMA PATIENTS - NO PROGRESS DURING 2 DECADES, British Journal of Haematology, 102(1), 1998, pp. 354-355
Citation: E. Nord et al., COST-UTILITY ANALYSIS OF MELPHALAN PLUS PREDNISONE WITH OR WITHOUT INTERFERON-ALPHA-2B IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - RESULTS FROM ARANDOMIZED CONTROLLED TRIAL, PharmacoEconomics, 12(1), 1997, pp. 89-103
Authors:
SCHULMAN S
GRANQVIST S
HOLMSTROM M
CARLSSON A
LINDMARKER P
NICOL P
EKLUND SG
NORDLANDER S
LARFARS G
LEIJD B
LINDER O
LOOGNA E
GUSTAFSSON C
GRONDAHL A
RHEDIN AS
TORNEBOHM E
LOCKNER D
JOHNSSON H
KOBOSKO J
MALMROS B
ARCINI N
SAAW J
STIG R
VIERING S
LJUNGBERG B
WILHELMSSON S
OHLSSON A
WALTER H
MALMQVIST K
ALKHALILI F
PETRESCU A
BROHULT J
HULTING J
SVENSSON E
DAHLIN L
BOBERG J
MARJANOVICS B
JONSSON KA
MALM C
HJORTH M
LINDGREN A
FAGRELL B
KALLNER M
WADMAN B
SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
Citation: F. Wisloff et M. Hjorth, HEALTH-RELATED QUALITY-OF-LIFE ASSESSED BEFORE AND DURING CHEMOTHERAPY PREDICTS FOR SURVIVAL IN MULTIPLE-MYELOMA, British Journal of Haematology, 97(1), 1997, pp. 29-37
Authors:
SCHULMAN S
WIMAN B
CARLSSON A
GUSTAFSSON C
GRONDAHL A
RHEDIN AS
TORNEBOHM E
JOHANSSON M
LOCKNER D
LINDMARKER P
JOHNSSON H
NICOL P
KOBOSKO J
MALMROS B
ARCINI N
SAAW J
LOOGNA E
STIG R
VIERING S
LJUNGBERG B
WILHELMSSON S
OHLSSON A
WALTER H
MALMQVIST K
ALKHALILI F
LEIJD B
PETRESCU A
BROHULT J
LARFARS G
HULTING J
EKLUND SG
SVENSSON E
DAHLIN L
BOBERG J
NORDLANDER S
MARJANOVICS B
LINDER O
JONSSON KA
MALM C
HJORTH M
FAGRELL B
KALLNER M
GRANQVIST S
EGBERG N
SCHULMAN S
WADMAN B
SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
Authors:
HJORTH M
HOLMBERG E
RODJER S
TAUBE A
WESTIN J
Citation: M. Hjorth et al., PHYSICIANS ATTITUDES TOWARD CLINICAL-TRIALS AND THEIR RELATIONSHIP TOPATIENT ACCRUAL IN A NORDIC MULTICENTER STUDY ON MYELOMA, Controlled clinical trials, 17(5), 1996, pp. 372-386
Citation: M. Hjorth, REFINEMENT OF LA1.5BA1.5CU3O7-X FROM A TWINNED CRYSTAL, Acta crystallographica. Section C, Crystal structure communications, 52, 1996, pp. 1599-1601
Citation: F. Wisloff et al., EFFECT OF INTERFERON ON THE HEALTH-RELATED QUALITY-OF-LIFE OF MULTIPLE-MYELOMA PATIENTS - RESULTS OF A NORDIC RANDOMIZED TRIAL COMPARING MELPHALAN-PREDNISONE TO MELPHALAN-PREDNISONE PLUS ALPHA-INTERFERON, British Journal of Haematology, 94(2), 1996, pp. 324-332
Authors:
WISLOFF F
EIKA S
HIPPE E
HJORTH M
HOLMBERG E
KAASA S
PALVA I
WESTIN J
Citation: F. Wisloff et al., MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(3), 1996, pp. 604-613
Authors:
HJORTH M
WESTIN J
DAHL IMS
GIMSING P
HIPPE E
HOLMBERG E
LAMVIK J
NIELSEN JL
LOFVENBERG E
PALVA IP
RODJER S
TALSTAD I
TURESSON I
WISLOFF F
ZADOR G
AMSLERNORDIN S
POLGARY M
ODEN A
WALLGREN A
WILHELMSEN L
HELLQVIST L
HASSELBLOM S
CARNESKOG J
LINDQVIST O
HOFFMAN P
OLSSON K
THOLEN A
STOLT CM
RINDNER A
SVENSSON R
VAART J
HANSEN S
ENGQVIST L
LANNEMYR O
NILSSON PG
LINNE I
LILJA G
TALLROTH G
HALLGREN J
ANDERSSON B
BILLSTROM R
PERSSON S
SAMUELSSON T
ODEBERG H
ADRIANSSON M
TOVE H
STOBEUS N
HABBERSTAD J
END T
DAHLEN M
ERIKSSON M
ANAGRIUS N
ARONSON D
NEZADAL L
ERIKSSON K
HEDENUS M
RYDE J
WESTIN L
ANDERSSON LO
BJURMAN A
FORSBERG K
FORS D
WIKSTROM S
THULE B
BOLSOY U
LENNERMO K
STRAND T
PALVA I
ALMQVIST A
ISOMAA B
OKSANEN K
EIKA C
LY B
BRANDT E
WEYDE K
FOSSUM C
LOVASEN K
SPARBY JA
JACOBSEN EM
RINDE M
NYHUS S
KAHRS J
STEEN T
GRAVDAHL H
BORGE L
GROTTUM KA
FLOTTEROD O
STROM BR
KNUTSEN H
DRIVENES A
PAULSEN J
RIIS S
HAUGE PW
NESTHUS I
COLL P
HOLE KH
SAETER T
SINDRE T
BERENTSEN S
NES H
VAGSTAD G
HEIKKELA R
SHAMMAS V
LODEMEL B
SKOGEN OR
SORUM Y
KVAMBE V
BULL O
JAEGER S
INGVALDSEN PG
PEDERSEN K
HANSEN LT
ONKIEHONG M
HAUGNES T
STEFANSEN D
GADEBERG O
ABILDGAARD N
JANS H
MOURITSANDERSEN T
NEUBAUER B
CLAUSEN NT
MAGNUSSON S
EYJOLFSSON G
BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
Authors:
SCHULMAN S
RHEDIN AS
LINDMARKER P
CARLSSON A
LARFARS G
NICOL P
LOOGNA E
SVENSSON E
LJUNGBERG B
WALTER H
VIERING S
NORDLANDER S
LEIJD B
JONSSON KA
HJORTH M
LINDER O
BOBERG J
GUSTAFSSON C
GRONDAHL A
TORNEBOHM E
JOHANSSON M
LOCKNER D
JOHNSSON H
KOBOSKO J
MALMROS B
ARCINI N
SAAW J
STIG R
WILHELMSSON S
OHLSSON A
MALMQVIST K
ALKHALILI F
PETRESCU A
BROHULT J
HULTING J
EKLUND SG
DAHLIN L
MARJANOVICS B
MALM C
LINDGREN A
FAGRELL B
KALLNER M
GRANQVIST S
WIMAN B
EGBERG N
WADMAN B
SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
Authors:
HJORTH M
HOLMBERG E
RODJER S
TAUBE A
WESTIN J
Citation: M. Hjorth et al., PATIENT ACCRUAL AND QUALITY OF PARTICIPATION IN A MULTICENTER STUDY ON MYELOMA - A COMPARISON BETWEEN MAJOR AND MINOR PARTICIPATING CENTERS, British Journal of Haematology, 91(1), 1995, pp. 109-115
Authors:
WESTIN J
RODJER S
TURESSON I
CORTELEZZI A
HJORTH M
ZADOR G
Citation: J. Westin et al., INTERFERON ALFA-2B VERSUS NO MAINTENANCE THERAPY DURING THE PLATEAU-PHASE IN MULTIPLE-MYELOMA - A RANDOMIZED STUDY, British Journal of Haematology, 89(3), 1995, pp. 561-568
Authors:
HJORTH M
THORUP N
FREDERIKSEN P
BECHGAARD K
Citation: M. Hjorth et al., CRYSTAL-STRUCTURE OF A COMPLEX OF PERI-XANTHENOXANTHENE (PXX) WITH TETRACYANOQUINODIMETHANE (TCNQ), Acta chemica Scandinavica, 48(2), 1994, pp. 139-143
Authors:
KNUDSEN LM
HIPPE E
HJORTH M
HOLMBERG E
WESTIN J
Citation: Lm. Knudsen et al., RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS, European journal of haematology, 53(4), 1994, pp. 207-212